SCHEMBL16701236

SCHEMBL16701236

c1cc2c(nn1)C1CCC2C1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.31
ACHE P22303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29127812 0.71 PDK2 (0.41) BCHEACHE
SCHEMBL15963988 0.68
SCHEMBL37753173 0.68 NR1I2 (0.31)
SCHEMBL31366252 0.68 CYP17A1 (0.35)
SCHEMBL23027852 0.67
SCHEMBL10716565 0.65 CHRNB2 (0.37)
SCHEMBL23082980 0.64 TAAR1 (0.30)
SCHEMBL14722340 0.63 PDE10A (0.36)
SCHEMBL13209315 0.62
SCHEMBL11862595 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3066082-B1 5,6,7,8-TETRAHYDRO-5,8-METHANOCINNOLINE DERIVATIVES AS RORC MODULATORS FOR THE TREATMENT OF AUTOIMMUNE DISEASES HOFFMANN LA ROCHE (CH) 2017-12-20 EP disclosed
EP-3066082-A1 5,6,7,8-TETRAHYDRO-5,8-METHANOCINNOLINE DERIVATIVES AS RORC MODULATORS FOR THE TREATMENT OF AUTOIMMUNE DISEASES F. Hoffmann-La Roche AG (CH) 2016-09-14 EP disclosed
EP-3066082-A1 5,6,7,8-TETRAHYDRO-5,8-METHANOCINNOLINE DERIVATIVES AS RORC MODULATORS FOR THE TREATMENT OF AUTOIMMUNE DISEASES F. Hoffmann-La Roche AG (CH) 2016-09-14 EP disclosed
CN-105705492-A 5,6,7, 8-tetrahydro-5, 8-methanocinnoline derivatives as RORC modulators for the treatment of autoimmune diseases 豪夫迈·罗氏有限公司 2016-06-22 CN disclosed
WO-2015067575-A1 5,6,7,8-TETRAHYDRO-5,8-METHANOCINNOLINE DERIVATIVES AS RORC MODULATORS FOR THE TREATMENT OF AUTOIMMUNE DISEASES F. HOFFMANN-LA ROCHE AG (CH) 2015-05-14 WO disclosed
WO-2015067575-A1 5,6,7,8-TETRAHYDRO-5,8-METHANOCINNOLINE DERIVATIVES AS RORC MODULATORS FOR THE TREATMENT OF AUTOIMMUNE DISEASES F. HOFFMANN-LA ROCHE AG (CH) 2015-05-14 WO disclosed